Bluejay Diagnostics, Inc. financial data

Symbol
BJDX on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
360 Massachusetts Avenue, Suite 203, Acton, MA
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 272 % -57.6%
Debt-to-equity 44.4 % +136%
Return On Equity -187 % -78.7%
Return On Assets -130 % -47%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.25M shares +511%
Common Stock, Shares, Outstanding 2.58M shares +153%
Entity Public Float 3.03M USD -85.8%
Common Stock, Value, Issued 258 USD +153%
Weighted Average Number of Shares Outstanding, Basic 483K shares +278%
Weighted Average Number of Shares Outstanding, Diluted 483K shares +278%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 249K USD
Research and Development Expense 5.05M USD -11.9%
Selling and Marketing Expense 305 USD -99.8%
General and Administrative Expense 4.01M USD -10.8%
Operating Income (Loss) -9.05M USD +16.6%
Nonoperating Income (Expense) 317K USD +200%
Net Income (Loss) Attributable to Parent -9.4M USD +12.1%
Earnings Per Share, Basic 9.3 USD/shares +76.7%
Earnings Per Share, Diluted 9.3 USD/shares +76.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 8.06M USD +58%
Inventory, Net 671K USD
Assets, Current 9.02M USD +37%
Property, Plant and Equipment, Net 1.55M USD +6.07%
Operating Lease, Right-of-Use Asset 263K USD -34.3%
Other Assets, Noncurrent 24.4K USD -22.9%
Assets 10.9M USD +28.1%
Accounts Payable, Current 490K USD +80.5%
Employee-related Liabilities, Current 534K USD +238%
Accrued Liabilities, Current 1.11M USD +28.3%
Liabilities, Current 2.06M USD +12.2%
Operating Lease, Liability, Noncurrent 151K USD -40.9%
Other Liabilities, Noncurrent 10.5K USD -25.7%
Liabilities 2.22M USD +5.53%
Retained Earnings (Accumulated Deficit) -31.8M USD -42.1%
Stockholders' Equity Attributable to Parent 8.64M USD +35.5%
Liabilities and Equity 10.9M USD +28.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.3M USD +21.7%
Net Cash Provided by (Used in) Financing Activities 2.78M USD
Net Cash Provided by (Used in) Investing Activities -35.4K USD +89.6%
Common Stock, Shares Authorized 7.5M shares 0%
Common Stock, Shares, Issued 2.58M shares +153%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.92M USD -190%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 8.06M USD +58%
Deferred Tax Assets, Valuation Allowance 7.69M USD +66.2%
Deferred Tax Assets, Gross 7.69M USD +66.2%
Operating Lease, Liability 279K USD -34.1%
Depreciation 19.7K USD -83.6%
Payments to Acquire Property, Plant, and Equipment 35.4K USD -89.6%
Lessee, Operating Lease, Liability, to be Paid 304K USD -35.7%
Property, Plant and Equipment, Gross 2.83M USD +16.5%
Operating Lease, Liability, Current 129K USD -23.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 100K USD -38.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 100K USD +18.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 24.2K USD -49.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 25K USD -75%
Deferred Tax Assets, Operating Loss Carryforwards 4.55M USD +49.6%
Lessee, Operating Lease, Liability, to be Paid, Year Four 25K USD -75%
Operating Lease, Payments 44.2K USD +1.49%
Additional Paid in Capital 28.7M USD +1.48%
Share-based Payment Arrangement, Expense -40.2K USD -109%